LifeMD, Inc. (LFMD)
2.79
+0.06
(+2.20%)
USD |
NASDAQ |
Oct 07, 16:00
2.805
+0.02
(+0.54%)
After-Hours: 20:00
LifeMD Enterprise Value : 114.29M for Oct. 7, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 07, 2026 | 114.29M |
| October 06, 2026 | 111.43M |
| October 05, 2026 | 110.95M |
| October 02, 2026 | 111.90M |
| October 01, 2026 | 117.16M |
| September 30, 2026 | 119.56M |
| September 29, 2026 | 118.60M |
| September 28, 2026 | 120.99M |
| September 25, 2026 | 122.90M |
| September 24, 2026 | 120.03M |
| September 23, 2026 | 126.73M |
| September 22, 2026 | 138.68M |
| September 21, 2026 | 135.10M |
| September 18, 2026 | 134.86M |
| September 17, 2026 | 133.90M |
| September 16, 2026 | 134.38M |
| September 15, 2026 | 143.47M |
| September 14, 2026 | 145.38M |
| September 11, 2026 | 126.73M |
| September 10, 2026 | 125.77M |
| September 09, 2026 | 122.19M |
| September 08, 2026 | 128.64M |
| September 04, 2026 | 128.16M |
| September 03, 2026 | 126.73M |
| September 02, 2026 | 127.68M |
| Date | Value |
|---|---|
| September 01, 2026 | 129.12M |
| August 31, 2026 | 128.64M |
| August 28, 2026 | 131.03M |
| August 27, 2026 | 136.77M |
| August 26, 2026 | 135.81M |
| August 25, 2026 | 136.29M |
| August 24, 2026 | 131.03M |
| August 21, 2026 | 139.16M |
| August 20, 2026 | 137.73M |
| August 19, 2026 | 143.47M |
| August 18, 2026 | 137.25M |
| August 17, 2026 | 139.64M |
| August 14, 2026 | 145.86M |
| August 13, 2026 | 146.33M |
| August 12, 2026 | 138.20M |
| August 11, 2026 | 142.51M |
| August 10, 2026 | 153.99M |
| August 07, 2026 | 151.12M |
| August 06, 2026 | 143.47M |
| August 05, 2026 | 156.86M |
| August 04, 2026 | 167.38M |
| August 03, 2026 | 159.25M |
| July 31, 2026 | 148.25M |
| July 30, 2026 | 154.94M |
| July 29, 2026 | 154.94M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Retrieve Medical Holdings, Inc. | 26.35M |
| eXoZymes, Inc. | 46.85M |
| HeartFlow, Inc. | 4.145B |
| ACADIA Pharmaceuticals, Inc. | 2.500B |
| Agenus, Inc. | 587.26M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.084M |
| Revenue (Quarterly) | 47.28M |
| Total Expenses (Quarterly) | 54.36M |
| EPS Diluted (Quarterly) | -0.1645 |
| Gross Profit Margin (Quarterly) | 79.67% |
| Profit Margin (Quarterly) | -14.98% |
| Earnings Yield | -18.50% |
| Normalized Earnings Yield | -17.87 |